[1]Torre LA, Siegel RL, Jemal A. Lung cancer statistics[J]. Advances in Experimental Medicine and Biology, 2016, 893: 1-19.
[2]Walter JE, Heuvelmans MA, Ten Haaf K, et al. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study[J]. Thorax, 2019, 74(3): 247-253.
[3]Koning HJ, Aalst CM, Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized Trial[J]. New England Journal of Medicine, 2020, 382(6): 503-513.
[4]Yousaf-Khan U, Aalst C, Jong PA, et al. Risk stratification based on screening history: the NELSON lung cancer screening study[J]. Thorax, 2017, 72(9): 819-824.
[5]Rojewski AM, Tanner NT, Dai L, et al. Tobacco dependence predicts higher lung cancer and mortality rates and lower rates of smoking cessation in the national lung screening trial[J]. Chest, 2018, 154(1): 110-118.
[6]陳文. 醫(yī)學影像技術(shù)研究進展及其發(fā)展趨勢[J]. 實用醫(yī)學影像雜志, 2016, 17(3): 254-258.
Chen W.?Research progress and development trend of medical imaging technology[J]. Journal of Practical Medical Imaging, 2016, 17(3): 254-258.
[7]Hong QY, Wu GM, Qian GS, et al. Prevention and management of lung cancer in China[J]. Cancer, 2015, 17:3080-3088.
[8]孫政,李綱,王洪軍等. 徐州市銅山區(qū)肺癌影響因素的病例對照研究[J].?中國腫瘤, 2013, 22(4): 266-269.
Sun Z, Li G, Wang HJ, et al. A case-control study on the influencing factors of lung cancer in Tongshan District, Xuzhou City[J]. China Cancer, 2013, 22(4): 266-269.
[9]Malhotra J, Malvezzi M, Negri E, et al. Risk factors for lung cancer worldwide[J]. European Respiratory Journal, 2016, 48(3): 889-902.
[10]黃萌, 陳星, 邱月鋒等.?肺癌危險因素及交互作用研究[J], 中華疾病控制雜志, 2011,?15(2):91-94.
Huang M, Chen X, Qiu YF, et al. Study on influencing factors and their interactions for lung cancer?[J]. Chinese Journal of Disease Control & Prevention, 2011, 15(2):91-94.
[11]?劉偉潔.?新確診肺癌患者戒煙效果及影響因素[J].?山東醫(yī)藥, 2015,?55(39):?112-113.
[12]耿睿, 孫宵, 李超等.?臨床因素與CT影像學特征對判斷孤立性肺結(jié)節(jié)良、惡性的價值[J]. 寧夏醫(yī)科大學學報, 2019, 41(05): 517-521.
Geng R, Sun X, Li C, et al. Value of clinical factors and CT imaging features in the diagnosis of benign and malignant solitary pulmonary nodules [J]. Journal of Ningxia Medical University, 2019, 41(05): 517-521.
[13]王晶晶, 高妮, 梁志剛等.?肺結(jié)節(jié)患者影像學特征分析[J]. 北京生物醫(yī)學工程,?2015,34(1):85-89.
Wang JJ, Gao N, Liang ZG, et al. Analysis based on imaging characteristics in patient with pulmonary nodules [J]. Beijing Biomedical Engineering, 2015,34(1):85-89.
[14]張子洲, 朱曄涵, 章斌.?PET-CT顯像中SUVmax在非小細胞肺癌診斷中的價值[J]. 江蘇醫(yī)藥, 2012, 38(4): 447-450.
Zhang ZZ, Zhu HH, Zhang B. The value of SUVmax in the diagnosis of non-small cell lung cancer[J]. Jiangsu Medical Journal, 2012, 38(4): 447-450.
Nambu A, Fau-Sato YKS, Fau-Okuwaki HST, et al. Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET[J].?European Respiratory Journal, 2016, 48(3): 889-902.
|